NOT:ETR
Novartis
145,66 €
arrow_downward
−0,74%(−1,08) 1D
6. nov., 17:35:44 GMT +1 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za NOT …
Odpri
143,24 €
Visoka
145,66 €
Nizka
142,26 €
Tržna kapitalizacija
335,52 mrd.
Povprečni promet
5,49 tis.
Promet
3,31 tis.
52-tedenski najvišji tečaj
147,88 €
52-tedenski najnižji tečaj
107,00 €
Št. zaposlenih
75 tis.
Odpri
143,24 €
Visoka
145,66 €
Nizka
142,26 €
Tržna kapitalizacija
335,52 mrd.
Povprečni promet
5,49 tis.
Promet
3,31 tis.
52-tedenski najvišji tečaj
147,88 €
52-tedenski najnižji tečaj
107,00 €
Št. zaposlenih
75 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Seeking Alpha
·
pred 1 uro
Novartis is said to be abandoning Ionis heart drug after late-stage trial setback
Investing.com
·
pred 2 urama
Novartis shelves potential blockbuster pelacarsen as landmark study fails
Reuters
·
pred 3 urami
Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Vizitka: Novartis
Generalni direktorVasant Narasimhan
Št. zaposlenih75,3 tis.
Ustanovljeno7. mar. 1996
SedežBasel, Basel, Švica
SektorHealth Care
Panoga-
Spletno mestonovartis.com